It is notable that we did not identify ALS-associated nonsense mutations within CAV1 or CAV2. CAV1/CAV2 nonsense mutations would dramatically reduce gene expression irrespective of cell type or even developmental stage and may manifest a broad range of phenotypes, including motor neuron toxicity, but not specifically ALS. The gene discussed is CAV2; the disease is amyotrophic lateral sclerosis.